Informationen:
Fehler:
ID
13725
Beschreibung
A Study of Clofarabine in Older Patients With Acute Myeloid Leukemia (AML) for Whom Chemotherapy Is Not Suitable; ODM derived from: https://clinicaltrials.gov/show/NCT00924443
Link
https://clinicaltrials.gov/show/NCT00924443
Stichworte
Versionen (1)
- 01.03.16 01.03.16 -
Rechteinhaber
CC BY-NC 3.0
Hochgeladen am
1. März 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Acute Myeloid Leukemia NCT00924443
Eligibility Acute Myeloid Leukemia NCT00924443
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Acute Myeloid Leukemia NCT00924443
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
written informed consent
Item
provide signed, written informed consent
boolean
C0021430 (UMLS CUI [1])
untreated aml
Item
have untreated aml according to world health organization (who) classification
boolean
C0023467 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0332155 (UMLS CUI [1,2])
age, post-menopausal
Item
male or post-menopausal female ≥ 65 years of age
boolean
C0001779 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
C0232970 (UMLS CUI [2])
unsuitable for intensive chemotherapy
Item
unsuitable for intensive chemotherapy
boolean
C0392920 (UMLS CUI [1])
compliance behavior
Item
be able to comply with study procedures and follow-up examination
boolean
C1321605 (UMLS CUI [1])
contraception
Item
male patient who are fertile agree to use and effective barrier method of birth control to avoid pregnancies
boolean
C0700589 (UMLS CUI [1])
C0015895 (UMLS CUI [2])
C0015895 (UMLS CUI [2])
liver and renal function
Item
have adequate liver and renal function as indicated by certain laboratory values
boolean
C0232741 (UMLS CUI [1,1])
C0232804 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,2])
previous treatment with clofarabine
Item
received previous treatment with clofarabine
boolean
C0092777 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,2])
other chemotherapy or corticosteroids
Item
are receiving other chemotherapy or corticosteroids (low-dose corticosteroid for pre-medication purposes are allowed)
boolean
C0003392 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0001617 (UMLS CUI [2])
C0205394 (UMLS CUI [1,2])
C0001617 (UMLS CUI [2])
prior treatment
Item
have received prior treatment for leukemia. growth factor, cytokine support, leukopheresis or hydroxyurea will be allowed but must be discontinued at least 24 hours prior to start of treatment with clofarabine
boolean
C1514463 (UMLS CUI [1])
have a psychiatric disorder that would interfere with consent, study participation, or follow-up
Item
have a psychiatric disorder that would interfere with consent, study participation, or follow-up
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
active, uncontrolled systemic infection
Item
have an active, uncontrolled systemic infection
boolean
C0009488 (UMLS CUI [1])
participation status
Item
are currently participating in other investigational drug studies or having received other investigational drugs within the previous 30 days
boolean
C2348568 (UMLS CUI [1])
cns leukemia
Item
have symptomatic central nervous system (cns) involvement
boolean
C1332884 (UMLS CUI [1])
blast transformation of chronic myeloid leukemia or acute promyelocytic leukemia
Item
blast transformation of chronic myeloid leukemia or acute promyelocytic leukemia
boolean
C0005699 (UMLS CUI [1])
C0023487 (UMLS CUI [2])
C0023487 (UMLS CUI [2])